Momentum Metropolitan earnings soar Main South African businesses drive growth -- 1 of 55 -- Hillie Meyer Group Chief Executive Officer Key take-outs Reinvent and Grow Overview 1 2 -- 2 of 55 -- F2022 NHE of R4.4 billion (1 000) ( 500) - 500 1 000 1 500 2 000 Strong earnings growth F2022 F2021 F2020 Q1 Q1 Q1 Q2 Q2 Q2 Q3 Q3 Q3 Q4 Q4 Q4 Key take-outs -- 3 of 55 -- - 5 000 10 000 15 000 20 000 +31% +10% New business sales grow to R72.7 billion PVNBP Strong earnings growth Further sales growth Q1 Q1 Q1 Q2 Q2 Q2 Q3 Q3 Q3 Q4 Q4 Q4 F2022 F2021 F2020 Key take-outs -- 4 of 55 -- 0 50 100 150 200 250 VNB reduces to R626 million +159% -14% Strong earnings growth Further sales growth VNB lower Q1 Q1 Q1 Q2 Q2 Q2 Q3 Q3 Q3 Q4 Q4 Q4 F2022 F2021 F2020 Key take-outs -- 5 of 55 -- New business API grows to R627 million 0 50 100 150 200 -9% +12% Strong earnings growth Further sales growth VNB lower Momentum Insure sales recovery Q1 Q1 Q1 Q2 Q2 Q2 Q3 Q3 Q3 Q4 Q4 Q4 F2022 F2021 F2020 Key take-outs -- 6 of 55 -- Myriad solidifies product leadership Strong earnings growth Further sales growth VNB lower FastTrack Pricing Underwriting Onboarding Momentum Insure sales recovery Myriad innovation Key take-outs -- 7 of 55 -- Focused and product-specific rewards programmes Strong earnings growth Further sales growth VNB lower Wellness reinvented Risk-related discounts Cross-sell discounts Partner discounts Multiply and HealthReturns LifeReturns Safety Returns Momentum Life Momentum Metropolitan Health Momentum Insure LifeReturns HealthReturns Safety Returns Multiply Momentum Insure sales recovery Myriad innovation Key take-outs -- 8 of 55 -- Proposed transaction is confirmation of value created 0.0 0.5 1.0 1.5 2.0 Implied transaction value: R6.0 billion GWP (R’billion) Strong earnings growth Further sales growth VNB lower India JV comes of age Investment to date: R2.3 billion Current EV valuation: R2.1 billion Abu Dhabi Investment Authority proposes to acquire 10% interest in Aditya Birla Health Insurance H1 H2 F2022 F2021 F2018 F2019 F2020 H1 H2 H1 H2 H1 H2 H1 H2 Wellness reinvented Momentum Insure sales recovery Myriad innovation Key take-outs -- 9 of 55 -- Value unlocked for shareholders Strong earnings growth Further sales growth VNB lower Share buyback Buyback programme to continue if conditions favourable R750 million share buyback announced F2022 dividend of R1.5 billionIndia JV comes of age Wellness reinvented Momentum Insure sales recovery Myriad innovation Key take-outs -- 10 of 55 -- Reinvent and Grow -- 11 of 55 -- Grow existing channels Establish new channels Accelerate digital Product and service leadership NHE R5 billion >R500 million cost efficiencies ROE 20% Non-life insurance at 20% of NHE Market share +1% to +6% Transformation F2024 F2023 F2022 F2021 Reinvent and Grow update -- 12 of 55 -- Grow existing channels MDS 160 generalist to 150 specialist consultants MFP 250 new-to-industry planners 110 to 105 consultants Improved productivity Momentum Insure Consult by Momentum 290 to 315 active advisers Metropolitan Life 3 540 to 3 610 agents Continuous improvement -- 13 of 55 -- Establish new channels Momentum Life direct initiatives From 1% to 3% of Myriad APE Metropolitan Life Telechannel 12% of total Metropolitan Life APE in past two years Metropolitan GetUp From 1% to 2% of total Metropolitan Life APE Momentum Corporate retailisation 18% to 42% increase in Momentum Metropolitan share of preservations -- 14 of 55 -- Guardrisk General Insurance (GGI) grows to GWP of R2.8 billion Establish new channels - 500 1 000 1 500 2 000 2 500 3 000 F2019 F2020 F2021 F2022 GWP R’million F2022 F2021 F2020 F2019 -- 15 of 55 -- Guardrisk third party partnerships Establish new channels Guardrisk Life GWP R10.0 billion Guardrisk Insurance GWP 2.5 times Metropolitan Life in-force protection APE 2.3 times Momentum Insure GWP R6.6 billion -- 16 of 55 -- Accelerate Digital Adviser engagement Wealth re-platforming Migration and consolidation Single platform New savings policy administration system Project Rewire Digital movement gaining traction -- 17 of 55 -- Product and service leadership Wellness reinvented Myriad innovation Momentum Investments hybrid annuity Metropolitan Life limited underwriting product Momentum Corporate self- service solutions Health4Me leading product in low-income segment Investo self- service solutions -- 18 of 55 -- Junior Management Middle Management Senior Management Top Management F2022: 36% F2021: 36% F2022: 39% F2021: 36% F2022: 85% F2021: 84% F2022: 45% F2021: 42% Transformation Improvement in Employment Equity ACI representation iSabelo ESOP 3% shareholding 11 500 participants First full year of iSabelo -- 19 of 55 -- Main contributors >R500 million cost efficiencies Project Fit for Growth Wealth re-platforming AFI synergies Single platform Reduction in sales- related costs Project Rewire + Investo self- service MDS and MFP Migration -- 20 of 55 -- 0% 5% 10% 15% 20% 25% 30% Momentum Wealth Myriad FundsAtWork Momentum Insure Momentum Metropolitan Health Metropolitan Life F2020 to F2022 Market share +1% to +6% -- 21 of 55 -- Grow existing channels Establish new channels Accelerate digital Product and service leadership NHE R5 billion >R500 million cost efficiencies ROE 20% Non-life insurance at 20% of NHE Market share +1% to +6% Transformation F2024 F2023 F2022 F2021 Reinvent and Grow update -- 22 of 55 -- Momentum Metropolitan earnings soar Declares strong dividend and solidifies competitive position -- 23 of 55 -- Risto Ketola Group Finance Director Financial results 1 2 Financial year ended 30 June 2022 Conclusion Other topical matters 3 -- 24 of 55 -- F2022 F2020 F2019 F2021 1 521 3 074 1 007 4 383 >100% 1.0% 0.6% 1.1% 0.9% F2021 F2019 F2020 F2022 F2020 55 783 50 447 F2019 F2022 F2021 65 898 72 673 +10% 541 280 725 626 F2019 F2022 F2021 F2020 -14% Present value of premiums (R’million) Value of new business (R’million) New business margin (%) Normalised headline earnings (R’million)Key financial measures -0.2% -- 25 of 55 -- Return on equity (%) Dividend per ordinary share (cents) Return on embedded value per share (%) Diluted embedded value per share (R) 15.0% 7.5% 4.9% 22.7% F2021 F2019 F2020 F2022 +17.8% 9.4% -3.8% 6.3% 11.7% F2019 F2020 F2021 F2022 +5.4% 70 40 40 100 F2019 F2020 F2021 F2022 >100% 27.48 25.70 27.08 29.77 F2019 F2020 F2021 F2022 +10% Key financial measures -- 26 of 55 -- 883 512 610 435 578 340 393 177 (859) 435 (552) 938 672 Momentum Investments Momentum Life Metropolitan Life Momentum Corporate 1 110 1 095 1 174 >100% -14% +54% >100% F2019 F2020 F2021 F2022 Normalised headline earnings (R’million) SA life businesses -- 27 of 55 -- 166 164 262 (492) 534 156 405 317 (509) (336) 213 544 256 (358) 233 209 461 118 (466) 167 Non-life Insurance Shareholders Momentum Metropolitan Africa New Initiatives -15% -54% -30% -28% F2019 F2020 F2021 F2022 Normalised headline earnings (R’million) Other businesses Momentum Metropolitan Health -2% -- 28 of 55 -- Broad new business growth F2019 F2020 F2021 F2022 Present value of new business premiums (PVNBP) (R’billion) 8.3 23.1 4.9 17.0 2.5 55.8 7.1 26.8 4.7 9.2 50.5 7.5 41.5 5.9 8.2 7.3 42.5 7.2 12.2 3.5 Momentum Metropolitan Metropolitan Life Momentum Investments Momentum Life Momentum Corporate Momentum Metropolitan Africa 2.7 65.9 2.8 72.7 -3% +2% +22% +49% +22% +10% -- 29 of 55 -- 1.2% 0.4% 1.8% 1.6% 0.2% 1.0% 2.3% 1.0% 0.9% 1.1% -0.3% 0.8% 0.6% -0.3% 0.9% 0.3% Metropolitan Life Momentum Metropolitan Momentum Investments 0.6% Momentum Corporate Momentum Life Momentum Metropolitan Africa 0.7% 0.5% 3.4% 0.0% 0.1% -0.1% 4.3% -1.3% -0.1% -0.9% +0.5% -0.2% -0.2% New business margins weakened F2022 F2020 F2019 F2021 New business margin (%) -- 30 of 55 -- 189 146 82 124 100 60 90 30 106 228 172 219 157 243 23 203 6 000 8 000 10 000 12 000 14 000 16 000 18 000 20 000 22 000 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 PVNBP VNB F2020 F2019 F2021 F2022 VNB now more consistent with volumes PVNBP and VNB (R’million) -- 31 of 55 -- Steady embedded value growth 79% 80% 72% 73% 73% 17% 16% 23% 23% 22% 4% 4% 5% 5% 5% 38 524 40 407 41 328 43 906 45 428 Jun '20 Dec '20 Jun '21 Dec '21 Jun '22 EV Breakdown Covered business Non-covered: Established business Non-covered: New Initiatives R29.77 EV per share 11.7% ROEV per share Embedded value (R’million) -- 32 of 55 -- R301 million uplift for remaining shareholders Jun '22 Actual Buyback Pro-forma Embedded value (R’million) 45 428 (382) 45 046 Shares (million) 1 526 (23) 1 503 Diluted EV per share (Rands) 29.77 0.20 29.97 Pro-forma impact of the buyback on EV -- 33 of 55 -- Capital cover remains within or above target levels 2.08 1.85 1.73 2.03 0.0 0.5 1.0 1.5 2.0 2.5 F2022 F2021 F2020 F2019 Target range Momentum Metropolitan Life -- 34 of 55 -- 70 40 40 100 F2022 F2019 F2020 F2021 +150% Dividend cover of 2.9 times NHE Dividend cover target range remains at 2.0 to 3.0 times NHE Dividend increased to 2.5x F2021 level Dividend per share (cents) -- 35 of 55 -- Mortality claims experience Cash generation India proposed transaction Other topical matters 1 2 3 -- 36 of 55 -- Mortality claims experience -- 37 of 55 -- 677 553 964 733 1 507 908 1 483 695 665 619 267 286 500 414 644 436 580 393 374 403 945 829 1 071 1 126 2 080 1 441 3 028 1 635 1 146 1 235 Q2 Q3 Q2 Q3 Q1 Q4 Q4 Q1 Q3 4 231 Q4 1 889 1 668 2 535 2 273 2 785 5 091 2 723 2 185 2 257 Momentum Life Metropolitan Life Momentum Corporate Mortality levels remain elevated Amount of death claims (R’million) F2020 F2021 F2022 -- 38 of 55 -- India proposed transaction -- 39 of 55 -- Funds raised will be used to fund accelerated growth. Capital infusion reduces planned capital injection by R600 – R700 million. Implied valuation would result in 8.5% uplift to EV if valuation were adopted. ABHI shareholding: 45.91% held by ABCL | 44.10% held by MMH | 9.99% held by ADIA India proposed transaction Transaction terms value MMH stake at R6 billion, a premium of R4 billion above EV. 1 2 3 4 5 -- 40 of 55 -- Cash generation -- 41 of 55 -- The 4 cash generating entities -- 42 of 55 -- Remittances in the last 2 years 21 1 914 39 3 706 F2021 F2022 R’m 134 330375 408 F2021 F2022 R'm 35 239 213 209 F2021 F2022 R'm 545 204256 118 F2021 F2022 R'm Cash remittances to MMH Normalised headline earnings SA Life Guardrisk Africa Health F2021 F2022 F2021 F2022 F2021 F2022 F2021 F2022 -- 43 of 55 -- SA Life Guardrisk Health Africa R1.8bn to R2.0bn ±R300m ±R200m ±R200m Normal year should see ± R2.5bn Normal remittances to MMH -- 44 of 55 -- Additional dimensions to consider Sales or purchases of businesses – last two years we have been “net sellers” with the sale of aYo and Aluwani. Momentum Insure expected to pay decent remittances once profitability is restored. Investment management operations paying small remittances, amount should increase going forward. Earnings from VC funds only convert to cash on realisation. Investment phase is largely over. 1 2 3 4 -- 45 of 55 -- (343) (433) (230) (338) F2021 F2022 India JV the largest investment for the Group Capital injections Normalised headline earnings India JV – MMH capital injections and share of NHE (R’million) F2021 F2022 -- 46 of 55 -- 415 2 400 599 592 1 498 1 983 4 383 F2021 We like to pay dividends Dividend paid Other F2022 MMH dividend paid and NHE (R’million) Cash generated to MMH 1 007 -- 47 of 55 -- How it all comes together Net capital flow R’million SA Life 1 914 Guardrisk 330 Health 239 Africa 204 Other 62 Net M&A 192 India (433) Preference shares (108) Cash generated to MMH 2 400 Ordinary dividend (1 498) Net of dividend payment 902 Approved buyback (750) Net of buyback & dividend 152 -- 48 of 55 -- In conclusion -- 49 of 55 -- In conclusion 1 Strong financial results reflective of the focus over the past few years. -- 50 of 55 -- In conclusion 1 2 Strong financial results reflective of the focus over the past few years. Privileged to be in a financial position to implement a buyback and to pay decent dividends concurrently. -- 51 of 55 -- In conclusion 1 2 3 Strong financial results reflective of the focus over the past few years. Several exciting projects and initiatives on the go where the next 18 months will be telling. Privileged to be in a financial position to implement a buyback and to pay decent dividends concurrently. -- 52 of 55 -- In conclusion 1 2 3 Strong financial results reflective of the focus over the past few years. Several exciting projects and initiatives on the go where the next 18 months will be telling. Privileged to be in a financial position to implement a buyback and to pay decent dividends concurrently. 4 It has been great to see staff returning to the office and to see the energy and idea generation picking up. -- 53 of 55 -- In conclusion 1 2 3 Strong financial results reflective of the focus over the past few years. Several exciting projects and initiatives on the go where the next 18 months will be telling. Privileged to be in a financial position to implement a buyback and to pay decent dividends concurrently. 4 5 Congratulations to our staff and thank you to our clients. It has been great to see staff returning to the office and to see the energy and idea generation picking up. -- 54 of 55 -- 1 2 3 Strong financial results reflective of the focus over the past few years. Several exciting projects and initiatives on the go where the next 18 months will be telling. Privileged to be in a financial position to implement a buyback and to pay decent dividends concurrently. In conclusion 4 5 Congratulations to our staff and thank you to our clients. It has been great to see staff returning to the office and to see the energy and idea generation picking up. -- 55 of 55 --